Savara says it will in the first of half next year seek an FDA license to treat autoimmune pulmonary alveolar proteinosis ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

and monogenic entities where senescence or alveolar stem cell exhaustion is not the primary pathogenetic mechanism. This narrative review, the first in a series of four, synthesizes current knowledge ...

A panel of experts, including Dr Rohit Aggarwal, Principal Investigator of the decentralized Myositis Interstitial Lung ...

It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, perivascular and perilymphatic tissues. The term ILD is used to distinguish these diseases from obstructive ...

A study found abnormal lung perfusion in long-COVID patients with normal CT scans, highlighting pulmonary vascular issues. At ERS 2024, researchers call for further investigation into the condition.

With the increasing incidence of lung cancer, the coexistence of pulmonary alveolar proteinosis (PAP) and lung cancer is becoming more common. However, the standard treatment protocols for patients ...

Pulmonary fibrosis (PF), also known as lung ... describe the major cell types of epithelial cells in the lungs, namely alveolar epithelial cells, airway epithelial cells, mesenchymal cells ...